<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04791293</url>
  </required_header>
  <id_info>
    <org_study_id>2630</org_study_id>
    <nct_id>NCT04791293</nct_id>
  </id_info>
  <brief_title>The Model for End-Stage Liver Disease Sodium (MELD-Na) Score in Non-cirrhotic Patients With Gastric Cancer</brief_title>
  <official_title>Predictive Value of MELD-Na Score for Perioperative Complications in Non-cirrhotic Patients With Gastric Cancer</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Istanbul Training and Research Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Istanbul Training and Research Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Gastric cancer is the fifth most common cancer worldwide. Gastrectomy with lymphadenectomy is&#xD;
      still the most effective treatment modality, depending on the stage and location. Despite&#xD;
      many radiological, surgical and anesthetic innovations, serious complications such as&#xD;
      anastomotic leakage, intra-abdominal abscesses, wound complications are seen secondary to&#xD;
      gastrectomy. Many clinical studies have been conducted to prevent and predict these&#xD;
      complications.&#xD;
&#xD;
      The Model for End-Stage Liver Disease (MELD) score, in which bilirubin, international&#xD;
      normalized ratio (INR) and serum creatinine values were used to determine surgical risks in&#xD;
      patients scheduled for liver transplantation. Latter developed by adding serum sodium (Na) to&#xD;
      the formula. The MELD-Na score is used to predict postoperative complications in&#xD;
      non-cirrhotic patients because of its simple and easy calculation.Moreover, The Meld-Na score&#xD;
      was later used to predict complications for surgical procedures other than liver surgery such&#xD;
      as colorectal surgery.&#xD;
&#xD;
      In this study, we aimed to investigate the importance of the Meld-Na score in predicting the&#xD;
      perioperative and postoperative outcomes in patients with gastric cancer.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 1, 2020</start_date>
  <completion_date type="Anticipated">February 2023</completion_date>
  <primary_completion_date type="Anticipated">February 2022</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>2 Years</target_duration>
  <primary_outcome>
    <measure>MELD-Na score difference between the groups</measure>
    <time_frame>30 days</time_frame>
    <description>Importance of MELD-Na score in predicting postoperative complications in patients with gastric cancer</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Gastric Cancer</condition>
  <condition>Complication,Postoperative</condition>
  <condition>Complications; Gastrointestinal, Postoperative</condition>
  <condition>Morality</condition>
  <arm_group>
    <arm_group_label>Group 1</arm_group_label>
    <description>Patients with postoperative complications</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 2</arm_group_label>
    <description>Patients without postoperative complications</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>MELD-Na score</intervention_name>
    <description>MELD-Na scores will be compared between the groups</description>
    <arm_group_label>Group 1</arm_group_label>
    <arm_group_label>Group 2</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients undergoing gastrectomy due to gastric cancer&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients undergoing gastrectomy due to gastric cancer&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients with pulmonary, hepatic and renal disfunctions,&#xD;
&#xD;
          -  Patients with diagnosed with a different cancer in the last 5 years and&#xD;
&#xD;
          -  Pregnant patients&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Cihad Tatar, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Istanbul Training and Research Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Cihad Tatar, MD</last_name>
    <phone>+905336599889</phone>
    <email>tatarcihad@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Istanbul Training and Research Hospital</name>
      <address>
        <city>Istanbul</city>
        <zip>34029</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cihad Tatar</last_name>
      <phone>+905336599889</phone>
      <email>tatarcihad@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Omer Akay, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <reference>
    <citation>Coakley KM, Sarasani S, Prasad T, Steele SR, Paquette I, Heniford BT, Davis BR. MELD-Na Score as a Predictor of Anastomotic Leak in Elective Colorectal Surgery. J Surg Res. 2018 Dec;232:43-48. doi: 10.1016/j.jss.2018.04.012. Epub 2018 Jul 2.</citation>
    <PMID>30463752</PMID>
  </reference>
  <reference>
    <citation>Schlosser KA, Kao AM, Zhang Y, Prasad T, Kasten KR, Davis BR, Heniford BT, Colavita PD. MELD-Na score associated with postoperative complications in hernia repair in non-cirrhotic patients. Hernia. 2019 Feb;23(1):51-59. doi: 10.1007/s10029-018-1849-2. Epub 2018 Nov 16.</citation>
    <PMID>30446849</PMID>
  </reference>
  <reference>
    <citation>Yasri S, Wiwanitkit V. MELD-Na score and postoperative complications in hernia repair. Hernia. 2019 Aug;23(4):823. doi: 10.1007/s10029-019-01886-z. Epub 2019 Jan 22.</citation>
    <PMID>30671898</PMID>
  </reference>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>March 6, 2021</study_first_submitted>
  <study_first_submitted_qc>March 6, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 10, 2021</study_first_posted>
  <last_update_submitted>March 6, 2021</last_update_submitted>
  <last_update_submitted_qc>March 6, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 10, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Istanbul Training and Research Hospital</investigator_affiliation>
    <investigator_full_name>Cihad Tatar</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stomach Neoplasms</mesh_term>
    <mesh_term>Postoperative Complications</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

